PodcastsCiênciaJHLT: The Podcast

JHLT: The Podcast

ISHLT
JHLT: The Podcast
Último episódio

79 episódios

  • JHLT: The Podcast

    Episode 78: Barriers and Opportunities in DCD Heart Transplantation

    18/02/2026 | 12min
    JHLT: The Podcast returns with an episode  for our heart transplant colleagues, discussing the paper, "Barriers and opportunities in donation after circulatory death heart transplantation," from the February issue of JHLT.
    Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone.
    The discussion explores:
    Geographic variability on DCD heart utilization—why it happens and how to address
    Concerns around donor progression to circulatory arrest after life support withdrawal
    The volume of DCD hearts not utilized each year—and the gap between those successfully transplanted
    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
  • JHLT: The Podcast

    Episode 77: ISHLT Consensus Statement: Short Telomere Syndrome and Lung Transplantation

    04/02/2026 | 22min
    In this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on a new consensus statement from ISHLT on Short Telomere Syndrome (STS) and Lung Transplantation. The document was first published last month.
    They're joined by document leads Andrew Courtwright, MD, PhD, of the University of Pennsylvania in Philadelphia; Dr. John Mackintosh of Prince Charles Hospital in Brisbane; and John McDyer, MD, of the University of Pittsburgh Medical Center in Pittsburgh.
    The conversation includes discussion of:
    Recommendations for assessing patients for STS
    Which patients we should screen
    How the diagnosis influences transplant decision making and risk assessment
    How STS impacts immunosuppression
    Extrapulmonary comorbidities
    Future areas for research
    ISHLT Standards, Guidelines, and Consensus Statements are open to all at ISHLT.org.
    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
    Return later this month for a conversation on barriers and opportunities in utilizing DCD hearts in transplantation.
    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
  • JHLT: The Podcast

    Episode 76: Evolocumab's Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients

    21/01/2026 | 19min
    JHLT: The Podcast returns with an episode discussing the paper, "Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients," from the January issue of JHLT.
    Featured on this episode is early career guest host Bin Yang, MD, of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD, Dr. Yang shares hosting duties this episode and brings great questions to the discussion.
    Drs. Yang and Ton are joined by the first author, Salma Karim, and senior author, Hans Eiskjaer, both from Aarhus University Hospital in Denmark.
    The discussion explores:
    What imaging and physical markers the researchers used to determine if evolocumab was influencing the development of cardiac allograft vasculopathy (CAV)
    The potential role of lipid-lowering therapies or statins in treating CAV
    The relationship between CAV and microvascular resistance (IMR)
    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
    In case you missed it, earlier this month the JHLT Digital Media Editors recapped their favorite papers from 2025. Take a listen!
    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
  • JHLT: The Podcast

    Episode 75: A Look Back on 2025 in JHLT

    07/01/2026 | 14min
    Happy new year and welcome to a new season of JHLT: The Podcast! In this year-end recap, the Digital Media Editors will each share one of their favorite studies from The Journal of Heart and Lung Transplantation in 2025. You'll get a look at some of the best science in advanced heart and lung failure from the past year.
     
    Studies featured:
    Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
    Gomberg-Maitland M, et al. JHLT Apr 2025 44(4):609 – 624.
    A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices
    Lefkowitz DS, et al. JHLT Apr 2025 44(4):487-502.
    ABO-incompatible heart transplants in children aged 2-9 years: A new paradigm in transplant?
    Hollis P, et al. JHLT Dec 2025 44(12):1910-1917.
    Heart transplantation in Ukraine during wartime: A retrospective cohort study of standard vs marginal donor heart transplantation outcomes
    Todurov B, et al. JHLT Nov 2025 44(11):1728-1734.
     
    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
     
    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
  • JHLT: The Podcast

    Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

    17/12/2025 | 10min
    JHLT: The Podcast returns with an episode discussing the paper, "High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study," from the December issue of JHLT.
     
    They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.
     
    The discussion explores:
    Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA)
    How APS patients differed from non-APS patients in the PEA cohort
    The changes in clinical practice at Marie Lannelongue after the study's findings
     
    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
     
    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Mais podcasts de Ciência

Sobre JHLT: The Podcast

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.
Site de podcast

Ouça JHLT: The Podcast, Os três elementos e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções

JHLT: The Podcast: Podcast do grupo

Informação legal
Aplicações
Social
v8.7.0 | © 2007-2026 radio.de GmbH
Generated: 2/27/2026 - 1:04:30 PM